Table 4.

Diagnoses, Medications, and Medications Changes Discussed During Telephone Encounter from June 30, 2014 – December 31, 2017 for all 2,541 Telephone Consult Encounters with Health Care Providers^†

	n	%
Diagnoses Discussed
Unspecified depressive disorder	1301	51
Unspecified anxiety disorder	985	39
Major depressive disorder	233	9
PTSD	142	6
Opioid use disorder	140	6
Unspecified trauma/stress related disorder	98	4
ADHD	78	3
Panic disorder	59	2
Adjustment disorder	50	2
Cannabis use disorder	49	2
Bipolar I	41	2
Obsessive compulsive disorder	39	2
Schizophrenia	20	1
Alcohol use disorder	27	1
Cocaine use disorder	23	1
Complicated grief disorder	6	<1
Substance/medicated induced depressive disorder	5	<1
Persistent depression (dysthymia)	1	<1
Medications Discussed
SSRI	1260	50
Other antidepressants	419	17
Benzodiazepines	377	15
Atypical antipsychotics	251	10
Other sleep/anxiety agents	191	8
Lamotrigine	139	5
SNRI	90	4
Mood stabilizers	78	3
Lithium	52	2
Buprenorphine	34	1
Typical antipsychotics	34	1
Haloperidol	30	1
Methadone	25	1
Tricyclic antidepressant	21	1
Perphenazine	17	1
Medication Changes Discussed
Initiation	229	9
Change	143	6
Dose increase	218	9
Dose decrease	54	2
Taper	52	2
Additional medication started	210	8
Referral for medication treatment	160	6

PTSD=post-traumatic stress disorder; ADHD=attention deficit hyperactivity disorder;

SSRI=selective serotonin reuptake inhibitor; SNRI= Serotonin–norepinephrine reuptake inhibitors